Finch Therapeutics Group, Inc. (FNCHQ)
OTCMKTS · Delayed Price · Currency is USD
7.50
+0.10 (1.35%)
Apr 14, 2026, 2:46 PM EST
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $12.24 million as of April 15, 2026. Its market cap has decreased by -35.08% in one year.
Market Cap
12.24M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$7.50
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 12.24M, a decrease of -98.78%. That is a compound annual growth rate of -58.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 12.24M | -43.50% |
| Dec 31, 2025 | 21.66M | 19.35% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zeo ScientifiX | 15.36M |
| Oncotelic Therapeutics | 15.34M |
| HOOKIPA Pharma | 14.66M |
| Inhibitor Therapeutics | 13.81M |
| EOM Pharmaceuticals Holdings | 13.22M |
| Brainstorm Cell Therapeutics | 10.19M |
| ZIVO Bioscience | 9.60M |
| TRON Group | 9.57M |